Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Pari Basharat"'
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 15, Iss 1, Pp 1-5 (2019)
Abstract Background Omalizumab is a humanized monoclonal antibody widely used for treatment of persistent allergic asthma and antihistamine-refractory chronic urticaria. Immediate adverse events to omalizumab are well characterized. Delayed anaphylac
Externí odkaz:
https://doaj.org/article/64397fae9e294656863591295bbfe42e
Publikováno v:
SAGE Open Medical Case Reports, Vol 7 (2019)
This case report describes a novel presentation of a lichen planus and dermatomyositis overlap syndrome. The patient presented with pruritic and painful violaceous erythroderma with biopsy reports suggestive of both lichen planus and dermatomyositis.
Externí odkaz:
https://doaj.org/article/a4103c05afee4eb5947dd18b44ca4b8a
Autor:
Pari Basharat
Publikováno v:
European Medical Journal Rheumatology, Vol 3, Iss 1, Pp 128-135 (2016)
Idiopathic inflammatory myopathies (IIM) are traditionally identified as a group of disorders that target skeletal muscle due to autoimmune dysfunction. The IIM can be divided into subtypes based on certain clinical characteristics, and several class
Externí odkaz:
https://doaj.org/article/3f71e7090caf48478e7eb0aaca6c1391
Publikováno v:
Revue du Rhumatisme. 88:208-215
Introduction La recherche d’auto-anticorps est un examen tres regulierement utilise dans le cadre du depistage des maladies rhumatismales. Le facteur rhumatoide (FR) et les anticorps anti-nucleaires (ANA) ont une valeur predictive positive tres fai
Publikováno v:
Joint Bone Spine. 87:588-595
Introduction Autoantibody tests are commonly ordered when screening for rheumatic diseases. Rheumatoid factor (RF) and antinuclear antibody (ANA) have low positive predictive values in general practice. Overuse of diagnostic tests can result in an in
Publikováno v:
Seminars in Arthritis and Rheumatism. 57:152088
To evaluate the role of myositis-specific autoantibodies (MSAs) in interstitial lung disease (ILD), management of idiopathic inflammatory myopathies (IIM) associated ILD, and if there is a role for MSA specific management of ILD.A systematic review w
Publikováno v:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology
Allergy, Asthma & Clinical Immunology, Vol 15, Iss 1, Pp 1-5 (2019)
Allergy, Asthma & Clinical Immunology, Vol 15, Iss 1, Pp 1-5 (2019)
Background Omalizumab is a humanized monoclonal antibody widely used for treatment of persistent allergic asthma and antihistamine-refractory chronic urticaria. Immediate adverse events to omalizumab are well characterized. Delayed anaphylactoid and
Autor:
Arash H. Lahouti, Julie J. Paik, Lisa Christopher-Stine, Iago Pinal-Fernandez, Maria Casal-Dominguez, Andrew L. Mammen, Shivani Ahlawat, John A. Carrino, Thomas E. Lloyd, Pari Basharat, Sonye K. Danoff, Jemima Albayda
Publikováno v:
Annals of the Rheumatic Diseases. 76:681-687
ObjectivesThe aims of this study were to define the pattern of muscle involvement in patients with immune-mediated necrotising myopathy (IMNM) relative to those with other inflammatory myopathies and to compare patients with IMNM with different autoa
Autor:
Sherry Rohekar, Pari Basharat, A. Ahrari, S.S. Barrett, Janet E. Pope, Gina Rohekar, Sara Haig
Publikováno v:
FRIDAY, 15 JUNE 2018.
Background Laboratory testing including autoantibodies are common investigations ordered by physicians in diagnosing rheumatic diseases. Tests such as rheumatoid factor (RF) and antinuclear antibody (ANA) have been shown to have low positive predicti
Autor:
Sonye K. Danoff, Tanmayee Bichile, Pari Basharat, Iago Pinal-Fernandez, Livia Casciola-Rosen, Julie J. Paik, Jemima Albayda, Lisa Christopher-Stine, Thomas E. Lloyd, Andrew L. Mammen, Arash H. Lahouti
In addition to self-limited myotoxicity, statins have recently been shown to trigger an immune-mediated necrotizing myopathy (IMNM), which is distinguished from polymyositis (PM) and dermatomyositis (DM) by the absence of primary inflammation on musc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56126e12e076b2eb09e1820944bc34c6
https://europepmc.org/articles/PMC5640444/
https://europepmc.org/articles/PMC5640444/